Biosenta Inc. (CSE:ZRO)
Canada · Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
Sep 2, 2026, 12:37 PM EST
Biosenta Income Statement
Financials in millions CAD. Fiscal year is October - September.
Millions CAD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
| 0 | 0 | 0 | 0 | 0 | 0.17 | |
Revenue Growth | - | -12.18% | 32.34% | -9.47% | -99.31% | 10887.26% |
Cost of Revenue | 0 | 0 | 0 | 0 | 0.03 | 0.08 |
Gross Profit | 0 | 0 | 0 | -0 | -0.03 | 0.09 |
Selling, General & Admin | 1.33 | 1.19 | 1.06 | 1.41 | 1.08 | 2.02 |
Research & Development | 0.05 | 0.03 | 0.04 | 0.07 | 0.1 | 0.08 |
Operating Expenses | 1.38 | 1.23 | 1.1 | 1.48 | 1.19 | 2.1 |
Operating Income | -1.38 | -1.23 | -1.1 | -1.48 | -1.22 | -2.01 |
Interest Expense | -1.07 | -1.12 | -1.13 | -0.06 | -0.22 | -0.01 |
Currency Exchange Gain (Loss) | -0 | -0 | 0 | 0 | -0.01 | -0 |
Other Non Operating Income (Expenses) | -0.16 | -0.16 | 0.01 | 0.03 | -0.01 | -0.02 |
EBT Excluding Unusual Items | -2.61 | -2.51 | -2.23 | -1.51 | -1.46 | -2.04 |
Gain (Loss) on Sale of Investments | - | - | - | -4.79 | - | - |
Pretax Income | -2.61 | -2.51 | -2.23 | -6.3 | -1.46 | -2.04 |
Net Income | -2.61 | -2.51 | -2.23 | -6.3 | -1.46 | -2.04 |
Net Income to Common | -2.61 | -2.51 | -2.23 | -6.3 | -1.46 | -2.04 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 35 | 33 | 30 | 26 | 21 | 18 |
Shares Outstanding (Diluted) | 35 | 33 | 30 | 26 | 21 | 18 |
Shares Change | 7.35% | 12.54% | 13.05% | 22.74% | 19.71% | 11.27% |
EPS (Basic) | -0.07 | -0.08 | -0.08 | -0.24 | -0.07 | -0.11 |
EPS (Diluted) | -0.08 | -0.08 | -0.08 | -0.24 | -0.07 | -0.11 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 |
Free Cash Flow | -0.46 | -0.48 | -0.78 | -0.57 | -0.5 | -0.67 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.03 | -0.02 | -0.02 | -0.04 |
Gross Margin | 31.77% | 46.82% | 60.55% | -291.36% | - | 54.23% |
Operating Margin | -37796.99% | -101556.48% | -80027.12% | -142275.24% | -105790.62% | -1194.37% |
Profit Margin | -71521.27% | -206924.36% | -161543.00% | -604582.92% | -126695.14% | -1214.64% |
Free Cash Flow Margin | -12684.27% | -39738.81% | -56515.45% | -54351.92% | -43825.63% | -399.92% |
EBITDA | -1.38 | -1.23 | -1.1 | - | - | - |
D&A For EBITDA | 0 | 0 | 0 | - | - | - |
EBIT | -1.38 | -1.23 | -1.1 | -1.48 | -1.22 | -2.01 |
Revenue as Reported | - | - | - | - | - | 0.17 |